121 related articles for article (PubMed ID: 29437570)
21. Inhibitory effect of trichostatin on allograft rejection of corneal transplantation in rats.
Maimaitiming R; Yang X; Wupuer K; Ye N; Pan Z
Int J Clin Exp Med; 2015; 8(8):12424-9. PubMed ID: 26550154
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of subconjunctival cyclosporin-containing microspheres on keratoplasty rejection in the rabbit.
de Rojas Silva MV; Rodríguez-Ares MT; Sánchez-Salorio M; Lamas Díaz MJ; Cuevas Alvarez J; Vila Jato JL; Capeans Tomé C
Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):840-7. PubMed ID: 10502059
[TBL] [Abstract][Full Text] [Related]
23. Prevention of corneal allograft rejection in a mouse model of high risk recipients.
Vítová A; Filipec M; Zajícová A; Krulová M; Holán V
Br J Ophthalmol; 2004 Oct; 88(10):1338-42. PubMed ID: 15377562
[TBL] [Abstract][Full Text] [Related]
24. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats.
Pan Q; Xu Q; Boylan NJ; Lamb NW; Emmert DG; Yang JC; Tang L; Heflin T; Alwadani S; Eberhart CG; Stark WJ; Hanes J
J Control Release; 2015 Mar; 201():32-40. PubMed ID: 25576786
[TBL] [Abstract][Full Text] [Related]
25. Graft rejection and graft failure after penetrating keratoplasty or posterior lamellar keratoplasty for fuchs endothelial dystrophy.
Hjortdal J; Pedersen IB; Bak-Nielsen S; Ivarsen A
Cornea; 2013 May; 32(5):e60-3. PubMed ID: 23086366
[TBL] [Abstract][Full Text] [Related]
26. Use of anterior segment optical coherence tomography to predict corneal graft rejection in small animal models.
Liu YC; Lwin NC; Chan NS; Mehta JS
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6736-41. PubMed ID: 25249608
[TBL] [Abstract][Full Text] [Related]
27. [Experimental studies on the effect of the immunosuppressant FK-506 on penetrating keratoplasty rejection model in rats].
Lü L; Zhang W; Sun X
Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):25-8. PubMed ID: 11835769
[TBL] [Abstract][Full Text] [Related]
28. Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011).
Kharod-Dholakia B; Randleman JB; Bromley JG; Stulting RD
Cornea; 2015 Jun; 34(6):609-14. PubMed ID: 25811719
[TBL] [Abstract][Full Text] [Related]
29. High-dose subconjunctival cyclosporine a implants do not affect corneal neovascularization after high-risk keratoplasty.
Bock F; Matthaei M; Reinhard T; Böhringer D; Christoph J; Ganslandt T; Cursiefen C
Ophthalmology; 2014 Sep; 121(9):1677-82. PubMed ID: 24780407
[TBL] [Abstract][Full Text] [Related]
30. Topical cyclosporine in pediatric keratoplasty.
Cosar CB; Laibson PR; Cohen EJ; Rapuano CJ
Eye Contact Lens; 2003 Apr; 29(2):103-7. PubMed ID: 12695714
[TBL] [Abstract][Full Text] [Related]
31. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes.
Javadi MA; Feizi S; Karbasian A; Rastegarpour A
Br J Ophthalmol; 2010 Nov; 94(11):1464-7. PubMed ID: 20576763
[TBL] [Abstract][Full Text] [Related]
33. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
Shi WY; Liu T; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
[TBL] [Abstract][Full Text] [Related]
34. Presurgical corticosteroid treatment improves corneal transplant survival in mice.
Kim HK; Choi JA; Uehara H; Zhang X; Ambati BK; Cho YK
Cornea; 2013 Dec; 32(12):1591-1598. PubMed ID: 24005616
[TBL] [Abstract][Full Text] [Related]
35. A comparison of azithromycin and tobramycin eye drops on epithelial wound healing and tolerance after penetrating keratoplasty.
Blavin J; Sauer A; Saleh M; Gaucher D; Speeg-Schatz C; Bourcier T
J Ocul Pharmacol Ther; 2012 Aug; 28(4):428-32. PubMed ID: 22420841
[TBL] [Abstract][Full Text] [Related]
36. Endothelial keratoplasty versus repeat penetrating keratoplasty after failed penetrating keratoplasty: A systematic review and meta-analysis.
Wang F; Zhang T; Kang YW; He JL; Li SM; Li SW
PLoS One; 2017; 12(7):e0180468. PubMed ID: 28671976
[TBL] [Abstract][Full Text] [Related]
37. [An experimental study on subconjunctival interleukin-1 receptor antagonist for promotion of corneal transplant survival].
Zhai C; Zhang W; Zou L; Pan Z; Li N; Wu Y; Lu L; Zhang S; Ma D
Zhonghua Yan Ke Za Zhi; 2001 Jul; 37(4):270-2. PubMed ID: 11864435
[TBL] [Abstract][Full Text] [Related]
38. The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model.
Birnbaum F; Schwartzkopff J; Scholz C; Reis A; Reinhard T
Eye (Lond); 2007 Dec; 21(12):1516-23. PubMed ID: 17401326
[TBL] [Abstract][Full Text] [Related]
39. Topical FK-506 prevents experimental corneal allograft rejection.
Mills RA; Jones DB; Winkler CR; Wallace GW; Wilhelmus KR
Cornea; 1995 Mar; 14(2):157-60. PubMed ID: 7538061
[TBL] [Abstract][Full Text] [Related]
40. Topical pimecrolimus does not prolong clear graft survival in a rat keratoplasty model.
Birnbaum F; Schwartzkopff J; Scholz C; Reinhard T
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1717-21. PubMed ID: 17710430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
